bendamustine hyrochloride accord pdr/conc/soln for infus 2.5mg/ml (100mg)
accord healthcare limited - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
bendamustine hydrochloride accord 2.5mg/ml pdr/conc/soln for infusion (25mg)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
bendamustine hydrochloride accord 2.5mg/ml pdr/conc/soln for infusion (100mg)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
bendamustine hydrochloride 2.5mg/ml powder for concentrate for solution for infusion (25mg vial)
fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
bendamustine hydrochloride 2.5mg/ml powder for concentrate for solution for infusion(100mg vial)
fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
leukeran tablets 2 mg
padagis israel agencies ltd, israel - chlorambucil - tablets - chlorambucil 2 mg - chlorambucil - leukeran is indicated in the treatment of hodgkin's disease, indolent non-hodgkin's lymphoma, chronic lymphocytic leukaemia, and waldenstrom's macroglobulinaemia
alkeran tablets film-coated
excella gmbh & co.kg - melphalan - tablets film-coated - 2mg
leukeran tablets film-coated
excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg
bendamustine medac 100 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
bendamustine medac 100 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.